1. Introduction {#s0005}
===============

Women living in low- and middle-income countries (LMICs) present with cancer at more advanced stages and suffer higher mortality and morbidity from cancers than women living in high-income countries (HICs). Approximately 85% of women diagnosed with cervical cancer and 88% of deaths from cervical cancer are in LMICs ([@b0135]). Although women in Sub-Saharan Africa (SSA) make up 14% of the world's female population, over one-third of all global cervical cancer deaths occur in this region ([@b0215]). Mortality due to cervical cancer varies from 27.6 per 100,000 in East Africa to less than 2 per 100,000 person years in Western Asia, Australia-New Zealand and Europe ([@b0135]). In the case of breast cancer, incident rates are rapidly increasing in SSA and other LMICs. According to population-based registries, the pooled incidence rate of breast cancer in SSA increased from 19.7 per 100,000 to 36.9 per 100,000 from 2000 to 2015 ([@b0010]). Despite lower incidence rates in LMICs than HICs, mortality due to breast cancer is disproportionately higher. Countries in SSA, with weak health infrastructure and limited screening and/or prevention programs, have been affected by high cervical cancer burdens and high mortality-to-incidence ratios for breast cancer ([@b0075]).

Screening for both pre-invasive cervical abnormalities and early stage breast cancer has the potential to save lives as well as limit the costs and burdens on SSA health systems. Both breast cancer early detection and cervical cancer prevention are part of primary medical care in most HICs, and often these services are offered at the same medical visit. Furthermore, each service raises similar issues of privacy, dignity and women's empowerment that may either enhance or discourage their uptake in a given population.

Evidence-based global guidelines are available to support program planning, implementation and monitoring and evaluation efforts for cervical cancer screening and early detection of breast cancer programs, but uptake remains limited in the SSA. For example, in Kenya, only 13.8% and 13.5% of eligible women were screened for cervical and breast cancer, respectively ([@b0165]). It is important to assess the facilitators and barriers at the patient-, provider-, and system-level to address these gaps and improve women's access to cancer prevention services. In this literature review, we identify and describe patient-, provider-, and system-based 1) barriers that prevent the detection, diagnosis, and management of breast and cervical cancer in SSA, and 2) facilitators that can encourage women to seek education and care.

2. Methods {#s0010}
==========

2.1. Identifying the research question {#s0015}
--------------------------------------

Our overall research question in this scoping review was: What are the barriers to cervical cancer screening and early diagnosis of breast cancer and/or facilitators that enable these programs at the patient-, provider-, and system-levels in SSA countries? We identified scientific knowledge gaps surrounding this research question in the indexed literature over a 10-year period (2010--2020). A scoping review aims to "map the existing literature in a field of interest in terms of the volume, nature and characteristics of the primary research" ([@b0260]). The purpose of this review was not to appraise or synthesize the evidence base for effectiveness or feasibility of these programs in SSA, but rather to present a descriptive account of the facilitators and barriers that currently exist.

Several supplementary topics were used as secondary research objectives to guide our review. These consisted of themes in individual and community perceptions of cervical cancer screening and early diagnosis of breast cancer services in SSA, and examination of the current knowledge gaps that exist at the individual- and provider-levels that impact the ability of patients to seek and utilize screening and early diagnosis services. In addition, this review sought to highlight strategies that providers can implement to increase patient uptake of the current screening and early diagnosis programs as well as the resources and systematic changes that are needed to increase patient coverage and reduce cancer disparities in SSA.

2.2. Scoping review methodology and search strategy {#s0020}
---------------------------------------------------

The review methodology broadly followed the steps proposed by Levac et. al. ([@b0185]) with the development of research questions based on previous literature reviews on similar topics. Using the Cochrane guidelines ([@b0110]), we performed a literature search using Ovid MEDLINE, PubMed Central®, and Google Scholar to retrieve all studies published in English that contained information on facilitators and barriers to cervical cancer screening and early diagnosis of breast cancer within Sub-Saharan Africa. The subject search and text word search were done separately in each database and then combined using "OR" and "AND" operators. The MeSH (Medical Subject Headings) terms included "uptake," "barriers," "cancer," "cancer control," "culture," "sociocultural barriers," "enablers," "detection," "education," "system," "clinical," "provider," "breast," "cervical," "Africa," and "sub-Saharan Africa." We continued our search until we reached saturation, which was measured by citation of previously reviewed articles in new searches.

2.3. Selection criteria and quality assessment {#s0025}
----------------------------------------------

Irrespective of study design, original research studies that were conducted in community or hospital/clinic settings in SSA within the last 10 years (2010--2020) were included. Additional inclusion criteria consisted of publications written in the English language and studies that took place in the 46 of Africa's 54 countries designated as "sub-Saharan" by UNDP ([@b0320]). We excluded studies that were undertaken in other LMIC. In addition, letters and personal views were excluded from this study.

From March to June 2019, the titles and abstracts were independently screened in these searches, based on the inclusion and exclusion criteria. We selected a total of 397 publications, which were entered into a database and the full texts were downloaded. In an iterative process that involved removing publications that did not meet the inclusion criteria and adding relevant publications identified in a subset of review papers, the final list of publications for this review was determined (n = 46). In [Fig. 1](#f0005){ref-type="fig"}, a flow chart illustrates this process of literature selection.Fig. 1Results of the literature search.

2.4. Data extraction {#s0030}
--------------------

We extracted information from the selected publications that were relevant to our research questions. To aid our extraction process, we utilized a data extraction form developed by Udoh et. al. ([@b0315]) as illustrated in [Table 1](#t0005){ref-type="table"}. To ensure accuracy and consistency in the data extracted, we reviewed all accepted papers and evaluated each by research design, research quality, study replicability, and generalizability and coherence of the results. Our search was evaluated by all members of the team as well as within our academic network for expert opinions based on their experiences in cervical cancer screening and early diagnosis of breast cancer implementation and evaluation.Table 1Data extraction form adapted from [@b0315]).Senior authorDate of publicationStudy titleType of study designStudy setting (country)Geography setting (rural/urban)Study populationNumber of study participantsStudy findingsSignificant findingsConclusions

2.5. Limitations {#s0035}
----------------

We acknowledge some important limitations for this review. First, in this review, we looked for general themes in studies conducted across SSA and therefore sacrificed specificity. The countries of SSA are very diverse culturally, socially, and politically, perhaps more so than any other continent, although they tend to be lumped together. Therefore, while we broadly identified common facilitators and barriers, the development of interventions to increase the uptake of these cancer screenings in any local setting will likely require research to understand the contextual influences of socio-cultural and structural factors that impact participation in and/or adaptation of interventions accordingly. Finally, we acknowledge an inherent bias because not all countries and regions are represented, which is likely influenced by resources i.e., the locales that are the least resourced are likely to be the least represented in this review or any review of this kind since it requires infrastructure, resources, and accessibility to conduct research in such settings. Yet, this scoping review found common themes that might be a useful starting point for future dissemination and implementation (D&I), or D&I research, and a handy reference for identifying relevant studies.

3. Results {#s0040}
==========

The 46 articles included in this review are summarized in [Table 2](#t0010){ref-type="table"}. Thematic findings from our review have identified multiple facilitators and barriers of cervical cancer screening and early diagnosis of breast cancer for women living in SSA, which are presented in [Table 3](#t0015){ref-type="table"}. We distinguished various barriers and facilitators into individual-, provider-, and system-levels.Table 2Summary of the articles reviewed.AuthorYearPrimary Cancer SiteCountryGeographic SettingStudy PopulationStudy DesignAdedimeji et al ([@b0005])2017BreastNigeriaUrban/*peri*-urbanMen, women, and young adults in IbadanFocus group discussions (FGD)Almobarak et al ([@b0015])2016CervixSudanUrban/*peri*-urbanWomen aged between 14 and 58 that were recruited from obstetric clinics,\
governmental and private hospitals, and universities in Khartoum, SudanCross-sectional surveyAssoumou et al ([@b0020])2015CervixGabonUrban/*peri*-urbanWomen aged 16 years and older in Libreville, GabonStructured questionnaire interviewsBalekouzou et al ([@b0025])2016BreastCentral African RepublicUrban/*peri*-urbanHealth professionals working in hospitals in BanguiIndividual questionnairesBayu et al ([@b0030])2015CervixEthiopiaUrban/*peri*-urbanWomen (age ≥ 21 years) who have been living in Mekelle zone at least for six monthSemi-structured questionnaire interviewsBinka et al ([@b0035])2019CervixGhanaRuralWomen aged between 30 and 65 who were registered at the Battor Catholic Hospital but not yet screenedIn-depth interviewsBukirwa et al ([@b0040])2015CervixUgandaUrban/*peri*-urbanHealth care providers and adult women, aged 25+ years at the Mildmay HIV clinicKey informant interviews (KII) and in-depth interviewsChaka et al ([@b0045])2018Cervix; BreastEthiopiaRuralWomen aged 18+ yearsSemi-structured questionnaire interviewsCompaore et al ([@b0060])2016CervixBurkina FasoUrban/*peri*-urbanWomen referred from primary or secondary level public and private hospitals, community healthcare facilities, or Non-Governmental Organizations (NGO) for suspected dysplastic or cancer lesionsCross-sectional surveyDe Abreu et al ([@b0070])2013CervixSouth AfricaUrban/*peri*-urbanBlack women from Red Hill and Masiphumelele neighborhoods in Cape Town, aged 21--53 years oldFGDEbu et al ([@b0080])2014CervixGhanaRuralWomen who are 10--74 years and are sexually active in ElminaStructured questionnaire interviewEze et al ([@b0085])2012CervixNigeriaRuralFemale patients seeking care at the General Hospital at EnuohiaStructured questionnairesGrosse-Frie et al ([@b0095])2018BreastMaliUrban/*peri*-urbanBreast cancer survivors and women from BamakoFGDHasahya et al ([@b0105])2016CervixUgandaRuralWomen aged 25--49 years with daughters who received their HPV vaccinationFGDHoque ([@b0115])2010CervixSouth AfricaUrban/*peri*-urbanFemale first year students at Mangosuthu University of TechnologyStructured questionnaireIllaboya et al ([@b0125])2018BreastUgandaRuralWomen and community health workers in Ssisa sub-county in Wakiso districtSemi-structured interviewsIliyasu et al ([@b0120])2010CervixNigeriaUrban/*peri*-urbanFemale university students in northern NigeriaStructured questionnaire interviewsJoffe et al ([@b0140])2018BreastSouth AfricaUrban/*peri*-urbanWomen diagnosed at the Chris Hani Baragwanath Academic Hospital in 2015--2016Structured questionnaire interviewsKahesa et al ([@b0150])2012CervixTanzaniaUrban/*peri*-urbanWomen living in three wards from three municipals in Dar es SalaamStructured questionnaire interviewsKangmennaang et al ([@b0155])2018CervixKenyaRural and urban/*peri*-urban districtsWomen identified through cluster sampling from the 2014 Kenya Demographic and Health SurveyStructured questionnaire interviewsKassam et al ([@b0160])2015BreastTanzaniaUrban/*peri*-urbanSenior personnel involved in the 2010 "Check It, Beat It" campaign (CIBI2020)Semi-structured questionnaire interviewsKoneru et al ([@b0170])2017CervixTanzaniaUrban/*peri*-urbanWomen with HIV infection aged 19+ years attending HIV clinics in Dar es SalaamStructured questionnaireKoon et al ([@b0175])2013BreastUgandaUrban/*peri*-urbanMembers of Uganda Women's Cancer Support Organization (UWOCASO) aged 25--59 years and were breast cancer survivors at least one year from their time of diagnosisFGDLunsford et al ([@b0190])2017CervixKenyaRural and urban/*peri*-urban districtsWomen aged 25--49 years and male partners from urban Nairobi and rural NyanzaFGDMeacham et al ([@b0205])2016BreastUgandaUrban/*peri*-urbanBreast cancer survivors from Uganda that received treatment in Uganda or East AfricaStructured questionnaire interviewsMakurirofa et al ([@b0195])2019Cervix; BreastZimbabweRuralWomen aged 15--49 years old in Mudzi districtCommunity-based questionnaire surveyMcFarland ([@b0200])2013CervixBotswanaUrban/*peri*-urbanBlack women aged 30+ years living in GaboroneStructured questionnairesMingo et al ([@b0210])2012CervixBotswanaUrban/*peri*-urbanWomen attending general medicine or HIV clinics where Pap testing was availableStructured questionnairesMukama et al ([@b0220])2017CervixUgandaRuralWomen from Bugiri and Mayuge districtsCommunity-based questionnaire surveyMupepi et al ([@b0225])2010CervixZimbabweRuralWomen from Shamva districtDescriptive surveyNg'ida et al ([@b0230])2019BreastTanzaniaRuralWomen aged 35+ years in Morogoro districtStandardized questionnaireNgugi et al ([@b0235])2012CervixKenyaRural and urban/*peri*-urban districtsWomen living in Thika districtIn-depth interviewsNyanmbe et al ([@b0245])2019CervixZambiaRuralWomen and men from the general public resided in either Chilenje Township or Kanyama Compound of Lusaka CitySemi-structured questionnaire interviewObrist et al ([@b0250])2014BreastGhanaUrban/*peri*-urbanBreast cancer patients attending Komfo Anokye Teaching Hospital and their next of kinStructured questionnaireOlasehinde et al ([@b0255])2019BreastNigeriaRural and urban/*peri*-urban districtsWomen aged 40 years and older in Ife central and Iwo local districtSemi-structured questionnaire interviewsPorts et al ([@b0265])2015CervixSouth AfricaUrban/*peri*-urbanKey informants from Senzokuhle Home Based Care Workers, staff, and advocates as well as women from the communityIn-depth interviewsPruitt et al ([@b0270])2014BreastNigeriaRural and urban/*peri*-urban districtsWomen diagnosed with breast cancer and were seeking care at University College Hospital in IbadanSemi-structured interviewsRagan et al ([@b0275])2018CervixKenyaRural and urban/*peri*-urban districtsWomen aged 25--49 years or a man aged ≥18 years and married to a woman aged 25--49 years, a resident of Nairobi or NyanzaFGDRosser et al ([@b0285])2015CervixKenyaRuralStaff members at FACES/Ministry of Health (MoH)-supported cervical cancer screening and prevention sties in Suba and Mbita districtsStructured provider surveysSama et al ([@b0290])2017BreastCameroonRuralFemale undergraduate students in the Higher Teachers Training CollegeStructured questionnaireSayed et al ([@b0295])2016BreastKenyaRural and urban/*peri*-urban districtsWomen aged 15+ yearsKnowledge, attitudes, and practices (KAP) toolSayed et al ([@b0300])2019BreastKenyaRural and urban/*peri*-urban districtsWomen aged 15--49 years from the Integrated Primary Health Care (IPHC) database and male heads of householdFGD and KIITeng et al ([@b0305])2014CervixUgandaUrban/*peri*-urbanWomen attending the ASPIRE project and women unfamiliar with the Advances in Screening and Prevention in Reproductive Cancers (ASPIRE) projectSemi-structured interviews and FGDUtoo et al ([@b0330])2013CervixNigeriaUrban/*peri*-urbanWomen attending outpatient gynecological clinic at the Benue State University Teaching Hospital in MakurdiSemi-structured questionnaire interviewsWachira et al ([@b0340])2017BreastKenyaRuralAdult women aged 18+ years in western KenyaCognitive FGD using a breast cancer awareness measure (BCAM)Table 3Facilitators, barriers, and possible solutions for individual, provider, and system-level factors that impact cervical cancer screening and early diagnosis of breast cancer.LevelThemeFacilitatorsBarriersPossible SolutionsIndividualKnowledge and educationPerceived risk of developing cervical and/or breast cancer ([@b0030], [@b0040], [@b0070], [@b0080], [@b0115], [@b0200], [@b0210], [@b0220], [@b0235])Lack of significant knowledge and education surrounding cervical and breast cancer ([@b0245], [@b0020], [@b0125], [@b0230], [@b0290], [@b0045], [@b0060], [@b0300], [@b0040], [@b0070], [@b0080], [@b0115], [@b0225], [@b0085], [@b0330], [@b0255], [@b0095], [@b0175], [@b0195])Community and social support from members of their community such as religious and opinion leaders ([@b0235], [@b0245], [@b0305])Religious or cultural beliefs that explain causes of cancer ([@b0080], [@b0210], [@b0230], [@b0290], [@b0035])Local radio, television and multi-media public health campaigns ([@b0070], [@b0115], [@b0200], [@b0235], [@b0275], [@b0190], [@b0265], [@b0020], [@b0015], [@b0125], [@b0160], [@b0230], [@b0290], [@b0005], [@b0045])Beliefs that keep people from seeking health services ([@b0115], [@b0190], [@b0300])Misconceptions in patients' beliefs about cervical and breast cancer ([@b0210], [@b0220], [@b0225], [@b0030], [@b0040], [@b0070])ProviderKnowledge and educationEducation tailored with respect to their cultural or religious values ([@b0160])Poor physician-patient interactions ([@b0040], [@b0080], [@b0235], [@b0015], [@b0205], [@b0270], [@b0025], [@b0050])Increased training on specific screening and early detection techniques ([@b0285])Providing educational materials to patients ([@b0265], [@b0160], [@b0230], [@b0225])Providers did not offer sufficient education or advocacy ([@b0040], [@b0070], [@b0095], [@b0170])Providers' perceptions of patient acceptability ([@b0285])Gaps in education and knowledge amongst providers ([@b0265], [@b0125], [@b0045], [@b0095], [@b0195], [@b0025])IndividualAccessibilityPoor health status taking precedence over screening ([@b0040])Socioeconomic status and financial barriers ([@b0080], [@b0200], [@b0210], [@b0275], [@b0190], [@b0035], [@b0095])Inability to take time off from work or family responsibilities to seek care ([@b0070], [@b0210], [@b0140])IndividualHealth-related behaviors, attitudes, values, and practicesPoor individual screening behaviors and practices ([@b0015], [@b0300], [@b0205], [@b0035], [@b0270], [@b0225], [@b0085], [@b0255], [@b0095], [@b0175], [@b0340], [@b0150], [@b0170])Embarrassment ([@b0070], [@b0080], [@b0305], [@b0190], [@b0020], [@b0160], [@b0005], [@b0035])Fatalism ([@b0080], [@b0220], [@b0235], [@b0305], [@b0265], [@b0160], [@b0270], [@b0225], [@b0295])Fear ([@b0030], [@b0040], [@b0080], [@b0115], [@b0190], [@b0265], [@b0125], [@b0105], [@b0300], [@b0035], [@b0270], [@b0150], [@b0170], [@b0140])IndividualCommunity and social valuesLack of social support ([@b0275], [@b0005])Lack of support from spouse and spousal approval ([@b0080], [@b0115], [@b0235], [@b0275], [@b0305], [@b0190], [@b0105], [@b0300])Stigma in their community on utilizing cervical and/or breast cancer screening services ([@b0070], [@b0275], [@b0305], [@b0190], [@b0265], [@b0005], [@b0300], [@b0285], [@b0205])ProviderTrustEarn the respect and trust of patient ([@b0265], [@b0160], [@b0230], [@b0225], [@b0170])Poor physician-patient interactions ([@b0040], [@b0235], [@b0300], [@b0035], [@b0095], [@b0150])Use of nurses to facilitate cervical cancer screening and early detection of breast cancer programs ([@b0040], [@b0080], [@b0210], [@b0245], [@b0155], [@b0025], [@b0250])Motivating patients to engage in screening and/or early diagnosis programs ([@b0020])Female provider ([@b0040], [@b0080], [@b0210], [@b0245], [@b0045], [@b0295], [@b0170], [@b0155], [@b0025], [@b0250])SystemPersonal and community supportPeer-to-peer education and recruitment ([@b0305], [@b0205], [@b0170])Limited awareness of the availability of programs ([@b0140], [@b0025])Increased role of patient navigation programs to prevent loss to follow-up ([@b0170])Offering screening in more convenient places in their community ([@b0305], [@b0160], [@b0295])Time and accessibility issues with health facilities ([@b0235], [@b0275], [@b0190], [@b0125], [@b0005], [@b0035], [@b0225], [@b0150], [@b0170], [@b0040], [@b0070], [@b0080], [@b0105], [@b0300], [@b0285])Incorporating survivorship in education programs ([@b0205], [@b0270], [@b0175])Problems with equipment procurement and costs ([@b0040], [@b0005], [@b0300])SystemHealth infrastructureStaffing issues and hospital strikes ([@b0285], [@b0270])Lack of defined referral system ([@b0270])Problems with clinical pathways and insufficient patient tracking ([@b0040])SystemResource allocationProblems with supplies and equipment procurement ([@b0040], [@b0005], [@b0300])Integration of cancer screening within national HIV programs and other existing health programs ([@b0265])Cost of the screening procedure ([@b0080], [@b0035], [@b0270], [@b0085], [@b0330], [@b0150], [@b0140], [@b0120])Lack of equipment, resources and trained personnel to support cancer screening ([@b0125], [@b0005], [@b0285])SystemPolitical willLimited or flawed screening and patient management policies across SSA ([@b0125], [@b0005], [@b0105], [@b0300])Decentralizing health services ([@b0195])Limited health insurance coverage ([@b0080], [@b0200], [@b0225])

3.1. Individual-Level facilitators and barriers {#s0045}
-----------------------------------------------

### 3.1.1. Facilitators {#s0050}

The most salient individual factor that facilitated participation in cervical cancer screening was the patient's perceived risk ([@b0030], [@b0040], [@b0070], [@b0080], [@b0115], [@b0200], [@b0210], [@b0220], [@b0235]). One study reported that participants associated participation in cancer screening with the prevention of death or improvement in a patient's quality of life ([@b0275]). Additionally, the role of influential members of the community, such as religious and opinion leaders, led to increases in screening and vaccination participation ([@b0235], [@b0245], [@b0305]). The role of public health campaigns through local mass media were largely effective in not only an educational capacity, but also as a method to address community stigma against cancer screening methods ([@b0070], [@b0115], [@b0200], [@b0235], [@b0275], [@b0190], [@b0265], [@b0020], [@b0015], [@b0125], [@b0160], [@b0230], [@b0290], [@b0005], [@b0045]).

The factor that was most likely to serve as a facilitator or barrier on the individual-level was the patient's geographic setting with one study in particular indicating that participants from urban areas were more likely to be knowledgeable about risk factors and symptoms of cervical and breast cancer than those from rural areas ([@b0060]). In the case of cervical cancer, 57.64% ± 18.70% (SD: 16.8) of study participants in urban and *peri*-urban settings had an understanding of the disease compared with 44.96% ± 43.46% (SD: 24.4) of participants in rural areas. For breast cancer, 44.97% ± 6.80% (SD: 2.7) of participants based in urban and *peri*-urban settings were knowledgeable about breast cancer and early detection programs while 36.2% ± 44.34% (SD: 14.1) of participants from rural settings reported the same level of knowledge.

### 3.1.2. Barriers {#s0055}

Some of the major barriers for women seeking care were the lack of community and social support ([@b0275], [@b0005]), lack of support from spouse and spousal approval ([@b0080], [@b0115], [@b0235], [@b0275], [@b0305], [@b0190], [@b0105], [@b0300]) and stigma in their community in utilizing cervical and/or breast cancer screening services ([@b0070], [@b0275], [@b0305], [@b0190], [@b0265], [@b0005], [@b0300], [@b0285], [@b0205]). Several studies discussed the role of specific religious or cultural beliefs that may explain the causes of cancer ([@b0080], [@b0210], [@b0230], [@b0290], [@b0035]) or beliefs that keep people from seeking health services ([@b0115], [@b0190], [@b0300]). Several studies revealed major misconceptions in patients' beliefs including that they would know that they have cervical cancer from obvious symptoms ([@b0220], [@b0030], [@b0040], [@b0070]), as well as myths and misconceptions about Pap smears ([@b0040], [@b0210], [@b0225]).

Many of these barriers highlighted the overall lack of critical knowledge and education surrounding cervical and breast cancer ([@b0245], [@b0020], [@b0125], [@b0230], [@b0290], [@b0045], [@b0060], [@b0300], [@b0040], [@b0070], [@b0080], [@b0115], [@b0225], [@b0085], [@b0330], [@b0255], [@b0095], [@b0175], [@b0195]). As a result of limited cervical and breast cancer education, poor individual screening behaviors and practices persist throughout SSA. These included not having a breast exam, mammogram, or breast ultrasound within the last year ([@b0300], [@b0205], [@b0255], [@b0175], [@b0340]), dismissal of symptoms of early stage breast cancer ([@b0270], [@b0095]), limited awareness of the availability of programs in their area ([@b0035]), and having never been screened for cervical cancer ([@b0015], [@b0225], [@b0085], [@b0150], [@b0170]).

Other individual barriers involve accessibility and individual health-related behaviors, attitudes, values, and practices that prevent women from seeking cervical cancer screening and early diagnosis of breast cancer programs. These included embarrassment ([@b0070], [@b0080], [@b0305], [@b0190], [@b0020], [@b0160], [@b0005], [@b0035]), poor health status taking precedence over screening ([@b0040]), fatalism ([@b0080], [@b0220], [@b0235], [@b0305], [@b0265], [@b0160], [@b0270], [@b0225], [@b0295]), socioeconomic status and financial barriers ([@b0080], [@b0200], [@b0210], [@b0275], [@b0190], [@b0035], [@b0095]) and inability to take time off from work or family responsibilities to seek care ([@b0070], [@b0210], [@b0140]). Another major individual barrier was fear, particularly fear of pain during the screening procedure ([@b0030], [@b0040], [@b0080], [@b0115], [@b0265], [@b0035], [@b0150], [@b0170]), positive test results ([@b0040], [@b0115], [@b0190], [@b0300], [@b0150], [@b0140]), losing a breast ([@b0125], [@b0270]), and being infected in a health service setting ([@b0105]).

3.2. Provider-Level facilitators and barriers {#s0060}
---------------------------------------------

### 3.2.1. Facilitators {#s0065}

It was evident that the provider's role in providing health education to patients can serve as either a facilitator or a barrier. Women were most likely to seek care and follow up when they trusted their physician to be responsible for their disease management. Some ways to garner the trust and respect of patients included providing education to patients with respect to their cultural or religious values ([@b0160]), clear explanation of follow-up procedures ([@b0170]), and providing educational materials to their patients ([@b0265], [@b0160], [@b0230], [@b0225]). The majority of women in one particular study indicated that they were screened for cancer at the insistence of their provider ([@b0020]).

These studies in our review indicated a high level of dependency on the role of nurses to facilitate cervical cancer screening and early detection of breast cancer programs. Their roles included but were not limited to assisting or administering the questionnaires in these studies, serving as educators and patient navigators, granting interviews as key informants, performing screening (VIA, clinical breast examination, etc.) and registry activities ([@b0040], [@b0080], [@b0210], [@b0245], [@b0155], [@b0025], [@b0250]). Additionally, women in these studies generally reported a preference of a female physician or provider when asked ([@b0040], [@b0080], [@b0210], [@b0245], [@b0045], [@b0295], [@b0170], [@b0155], [@b0025], [@b0250]).

### 3.2.2. Barriers {#s0070}

Many provider characteristics and behaviors constituted barriers for patients in a clinical setting. Patients indicated that poor provider-patient interactions including hostile or unfriendly attitudes from health workers ([@b0040], [@b0235], [@b0035]), a lack of explanation of procedures ([@b0040]), feeling unformed ([@b0150]), and a lack of trust that providers will give patients the proper diagnosis ([@b0300], [@b0035], [@b0095]) prevented women from seeking screening services. Women indicated that they sought care through local practitioners such as pharmacists, nurses, and herbalists, rather than seeing a physician ([@b0300]). It was frequently highlighted that patients did not feel that their providers offered sufficient education or advocacy, which could be a major barrier to care ([@b0040], [@b0070], [@b0095], [@b0170]).

Gaps in relevant education and knowledge amongst providers was another barrier ([@b0265], [@b0125], [@b0045], [@b0095], [@b0195], [@b0025]). Providers in rural settings self-reported that they needed formal training on performing visual inspection after acetic acid (VIA) / visual inspection after Lugol's iodine (VILI) ([@b0285]). Furthermore, providers' perceptions regarding the acceptability of cancer prevention and screening amongst patients constituted as a barrier when providers believed patients were not likely to accept these services and were therefore less likely to offer them in the first place ([@b0285]).

3.3. System-level facilitators and barriers {#s0075}
-------------------------------------------

### 3.3.1. Facilitators {#s0080}

Several interventions in SSA were implemented to increase screening and early diagnosis programs with varying results. The most successful intervention strategies were focused on community and social support such as peer-to-peer education, navigation and recruitment ([@b0305], [@b0205], [@b0170]), offering screening in more convenient places in their community-based screening services and early diagnosis programs ([@b0305], [@b0160], [@b0295]), incorporating survivorship in education programs ([@b0205], [@b0270], [@b0175]) and leveraging the infrastructure and funding of existing HIV programs to integrate cancer screening services ([@b0265]). To counter the challenge of increasing uptake of screening and early diagnosis programs -- particularly among hard to reach populations, different strategies were proposed and implemented including decentralization of health services for cancer prevention strategies to facilitate scale up ([@b0195]) and an increased role of patient navigation programs to prevent loss to follow-up ([@b0170]) based on the needs and capacities in local settings.

### 3.3.2. Barriers {#s0085}

Overall, these studies highlighted a lack of health infrastructure, allocation of resources, and political will for cervical cancer screening and early breast cancer diagnosis as major barriers. This was seen in the limited or flawed screening and patient management policies across SSA ([@b0125], [@b0005], [@b0105], [@b0300]) and limited health insurance coverage ([@b0080], [@b0200], [@b0225]). A dearth of equipment, resources, and personnel for screenings and interventions was often noted ([@b0125], [@b0005], [@b0285]). Features of health systems that served as barriers to patients included lack of defined referral or follow-up system ([@b0270]), cost of the screening procedure ([@b0080], [@b0035], [@b0270], [@b0085], [@b0330], [@b0150], [@b0140], [@b0120]) and time burdens and accessibility issues ([@b0235], [@b0275], [@b0190], [@b0125], [@b0005], [@b0035], [@b0225], [@b0150], [@b0170], [@b0040], [@b0070], [@b0080], [@b0105], [@b0300], [@b0285]). This last factor included: hours of operation for clinics, issues of transportation to health facilities, location and accessibility of facilities, lack of privacy, long waiting times, unavailability of services in some locations, and lack of space in facilities for screening services. Potential causes of sub-optimal uptake included staffing issues and hospital strikes ([@b0285], [@b0270]), problems with supplies and equipment procurement ([@b0040], [@b0005], [@b0300]) and delays with clinical pathways and insufficient patient tracking ([@b0040]).

4. Discussion {#s0090}
=============

The screening and surveillance of breast and cervical cancer have been conducted together in demonstration projects from as early as the 1980s by the American Center for Disease Control (CDC) with Congress passing the Breast and Cervical Cancer Mortality Prevention Act of 1990 ([@b0180]). The high burden of both breast and cervical cancer mortality in LMICs, inequity in access to resources and services when compared to HIC, and the opportunity to reduce morbidity and mortality at early detection amongst both forms of cancer make for a natural synergy of research and implementation ([@b0065]).

While cervical cancer screening and early detection of breast cancer are separate clinical activities that may raise different issues in access and utilization, we chose to review them together given that each of these interventions are priorities for the World Health Organization and for Health Ministries within SSA. There is growing consensus that cancer prevention will need to be integrated into publicly available healthcare at the community level. Successful integration of these services will need to leverage facilitators and overcome the barriers identified in our review.

Based on this review, there are several priorities to be considered in development, implementation and evaluation of cervical cancer screening and early detection of breast cancer programs in SSA. These include financial investment and resource allocation to (1) community education programs to facilitate screening uptake tailored specifically to the setting; (2) enhanced education programs for providers and health workers with special consideration to those in rural areas; (3) task shifting screening and early detection activities from physicians to nurses and other health care workers; and (4) decentralized policy adaptions to meet the needs of rural populations. Many of the facilitators and barriers identified in this review are consistent with other, non-SSA LMIC.

On the individual-level, cultural and religious beliefs, concern for social and community support, and individual financial circumstances serve as the primary motivator of health behavior surrounding cancer screening and treatment utilization ([@b0130]). However, sufficient gaps in knowledge and education still exist across regional settings that inform individual perceptions and attitudes. In other LMIC countries, studies similarly indicate low levels of awareness of cancer risk factors and availability of screening services with no increase in cancer literacy over time, even amongst sub-populations with high educational and socioeconomic status ([@b0100], [@b0335]). Alternatively, The Union for International Cancer Control indicate that when regions invest financial and educational resources to improve cancer literacy in LMIC settings, patients in these regions are more likely to utilize screening and early detection programs ([@b0310]).

The results from this scoping review indicate that providers, especially those from rural areas, require more rigorous training programs to keep up to date with the current early diagnosis and screening methods and guidelines. Other studies and action plans also highlight the need for educating providers, including on patient-provider interactions ([@b0240], [@b0055]). Additionally, our review highlights the vast role that nurses play in the facilitation of screening and early detection programs, and the high level of trust that is placed in nurses in SSA context. Consideration should be taken to tailoring programs and interventions to utilize this goodwill through task shifting aspects of cervical cancer screening and early detection of breast cancer from physicians to nurses and other health care workers. Other similar studies highlight the importance of this strategy to broaden coverage and increase uptake in LMIC ([@b0145], [@b0050]).

A consistent theme in these barriers is the need for resource allocation and facilitation of educational programs at the patient- and provider-levels and increased accessibility of cancer screening by leadership at the national level. A major component of this is that health facilities are less accessible in rural settings than in populous urban and *peri*-urban settings, and information about screening and early detection is dispensed through social and community networks. Rahman et al., ([@b0280]) calls for decentralized policy adaptions to be tailored to a SSA rural context ([@b0280]). These include but are not limited to recruiting peer educators for health talks that are more personable and available than physicians to answer follow-up questions in order to increase knowledge, use of mobile clinics for areas with limited health infrastructure, and subsidized or free screening and early detection services. Several studies selected for this review highlight similar interventions to increase screening uptake and support decentralized models for screening implementation to adapt to the rural-specific context of patients in SSA.

Global health leadership indicate that regional and national commitment is required through Global Action Plan on Non-Communicable Diseases (2013--2023) and the global call to action to eliminate cervical cancer by WHO Director-General Dr. Tedros Adhanom (2018) ([@b0345], [@b0090]). Strategic investments in cancer control and implementation to ensure universal access to cancer care are required to achieve these objectives as well as the targets in the Sustainable Development Goals ([@b0325]). The WHO highlighted financing, partnership, legislative frameworks, policy integration, leadership and advocacy, development and allocation of human resources as key aspects to facilitating effective policy development ([@b0350]).

In conclusion, there is a need to strengthen political will related to these core policy features in order to develop robust national cervical cancer screening and early breast cancer diagnosis programs. Increased financial, human and political investments and research efforts are needed to sufficiently address the existing and increasing need for cancer prevention and treatment services. To ensure proper development of screening services and better clinical management of screening services and cancer prevention, it is necessary to enhance political and resource commitment and the development of public health interventions targeted at educating providers and their community about the risks of cervical and breast cancer and the benefits of screening as well as implementation of strategies to overcome barriers to cancer screening. In the absence of such commitments, it seems unlikely that the WHO goals to achieve cervical cancer elimination will be met and burden of breast cancer in SSA will continue to rise unchecked.
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